Migraines and Fluctuating Female Sex Hormones

The Role of Female Sex Hormones and CGRP

Migraines may be linked to fluctuating female sex hormones. Specifically, female sex hormones alongside calcitonin gene-related peptide (CGRP) are believed to play a crucial role in triggering migraines. Research indicates that variations in estrogen levels can enhance CGRP activity, potentially leading to migraine episodes. Studies have shown that women who experience migraines have elevated CGRP levels in their blood and tear fluid during menstruation, reinforcing this connection.

Understanding the Biology of Migraines

The biological mechanisms behind migraines are intricate and not entirely understood. The trigeminal nerve, which is responsible for facial sensations, releases CGRP, causing blood vessels in the head to dilate. During migraine attacks, this trigeminal system also releases CGRP, and treatments that inhibit CGRP activity have been found to alleviate symptoms.

The Menstrual Cycle and CGRP Interplay

Migraine occurrences are notably high and severe prior to menstruation and during peri-menopause when estrogen levels drop. The estrogen withdrawal hypothesis suggests that decreasing estrogen levels can instigate a migraine. While some individuals find relief from migraines through birth control methods that stabilize hormone levels, others may experience worsening symptoms.

Exploring the Mechanisms Behind Hormonal Influence

Research indicates that low estrogen levels can trigger CGRP release, contributing to migraine development. Individuals suffering from migraines have been found to have higher CGRP levels in their tear fluid, highlighting the significance of the trigeminal system in this context. This led to investigations into CGRP levels at various stages of the menstrual cycle in women.

The Study: Analyzing CGRP Levels and Hormonal Changes

A study was conducted to examine CGRP levels alongside changes in female sex hormones among women with and without migraines. Participants were categorized into three subgroups:
– Fertile women with regular menstrual cycles.
– Women using hormonal contraceptives.
– Postmenopausal women.

Results for Women with Regular Menstrual Cycles

During ovulation and just before menstruation, women with migraines exhibited higher CGRP levels in their tears and blood compared to those without migraines. Additionally, migraine sufferers had lower estrogen levels than their non-migraine counterparts during ovulation, although other female hormone levels remained similar between the two groups.

Results for Women on Hormonal Contraceptives

CGRP concentrations were comparable between women with and without migraines during both hormone-free and hormone-intake phases. Women without migraines showed lower estrogen and hormone levels in both phases, while testosterone levels remained stable.

Results for Post-Menopausal Women

Among post-menopausal women, hormone and CGRP levels were similar between those with and without migraines, showing no significant differences.

Interpreting the Study Findings

The findings indicate that women with migraines generally had higher CGRP levels compared to those without, except in post-menopausal or contraceptive-using groups. Moreover, fluctuations in hormone levels rather than their absolute values seemed to correlate with CGRP levels, aligning with the estrogen withdrawal hypothesis. The elevated CGRP levels associated with decreased estrogen prior to menstruation may explain the heightened frequency and severity of migraines during this time. However, increased CGRP levels have also been observed in areas unrelated to the trigeminal nerve in pregnant and post-menopausal women, suggesting the involvement of additional mechanisms.

Conclusion

Further investigation into the relationship between trigeminal CGRP levels in tear fluid and migraines may provide deeper insights into how female sex hormones influence migraine occurrences.

References

1. Edvinsson L. CGRP and migraine: from bench to bedside. Rev Neurol (Paris). Sep 2021;177(7):785-790. doi:10.1016/j.neurol.2021.06.003
2. Raffaelli B, Storch E, Overeem LH, et al. Sex Hormones and Calcitonin Gene-Related Peptide in Women With Migraine: A Cross-sectional, Matched Cohort Study. Neurology. Apr 25 2023;100(17):e1825-e1835. doi:10.1212/wnl.0000000000207114
3. Clinic C. Trigeminal Nerve. Accessed May 25, 2023. https://my.clevelandclinic.org/health/body/21581-trigeminal-nerve#:~:text=The%20trigeminal%20nerve%20is%20the,help%20you%20chew%20and%20swallow.
4. Kamm K, Straube A, Ruscheweyh R. Calcitonin gene-related peptide levels in tear fluid are elevated in migraine patients compared to healthy controls. Cephalalgia. Oct 2019;39(12):1535-1543. doi:10.1177/0333102419856640